Sandoz Recalls Potentially Carcinogenic Muscle Pain Pills
MedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsMedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsMedTruth Editors · April 6, 2022
Pfizer detected a potentially carcinogenic compound in the blood pressure lowering drug Accuretic.
NewsMedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsMedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsMedTruth Editors · April 6, 2022
Pfizer detected a potentially carcinogenic compound in the blood pressure lowering drug Accuretic.
NewsMedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsFebruary 15, 2022
December 13, 2021
October 21, 2021
September 29, 2021
August 17, 2021
October 15, 2020
September 8, 2020
September 1, 2020
June 12, 2020
May 29, 2020
May 28, 2020
April 1, 2020
March 4, 2020
February 11, 2020
January 28, 2020
January 15, 2020
January 8, 2020
January 14, 2020
January 13, 2020
January 7, 2020
November 5, 2019
January 11, 2017